Tina Loarte-Rodríguez: Understanding Inequities in Healthcare

Howie and Harlan are joined by Tina Loarte-Rodríguez, associate director, health equity measures, at Yale’s Center for Outcomes Research & Evaluation and the author of Latinas in Nursing: Stories of Determination, Inspiration, and Trust. And Howie and Harlan discuss the clinical and economic dimensions of two newly approved CRISPR-based treatments for sickle cell disease.  Links: Tina Loarte-Rodríguez Tina Loarte-Rodríguez: Latinas in Nursing: Stories of Determination, Inspiration, and Trust Center for Outcomes Research & Evaluation (CORE) Center for Outcomes Research & Evaluation: Quality Measurement “Sociodemographic Disparities in Queue Jumping for Emergency Department Care” New Treatments for Sickle Cell Disease “In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease” “F.D.A. Approves Sickle Cell Treatments, Including One That Uses CRISPR” The Nobel Prize in Chemistry 2020 Yale New Haven Health: Sickle Cell Program “Milestones in Sickle Cell Research and Care” Bluebird Bio Yahoo Finance: Bluebird Bio, Inc. “Tough road ahead for Bluebird Bio despite FDA approval for sickle cell therapy” “Harlan M. Krumholz Named Next Editor-in-Chief of JACC” Read an unedited transcript of this episode. Learn more about the MBA for Executives program at Yale SOM. Learn more about the Pozen-Commonwealth Fund Fellowship in Health Equity Leadership. Email Howie and Harlan comments or questions.